Publication | Closed Access

Anti-tumor compound RY10-4 suppresses multidrug resistance in MCF-7/ADR cells by inhibiting PI3K/Akt/NF-κB signaling

Tumor BiologyMedicineImmunologyCancer Cell BiologyMultidrug ResistanceAnti-tumor Compound Ry10-4Cancer BiologyAnti-cancer AgentTumor SuppressorPharmacologyRadiation OncologyCell SignalingCancer ResearchPi3k/akt/nf-κb Signaling